BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 29174680)

  • 1. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Value Health; 2020 Jul; 23(7):891-897. PubMed ID: 32762991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of supplementary immunization activities on routine vaccination coverage: An instrumental variable analysis in five low-income countries.
    Chakrabarti A; Grépin KA; Helleringer S
    PLoS One; 2019; 14(2):e0212049. PubMed ID: 30763389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
    Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
    Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
    Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
    Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal gaps in measles vaccination coverage in Madagascar.
    Mensah K; Heraud JM; Takahashi S; Winter AK; Metcalf CJE; Wesolowski A
    Vaccine; 2019 Apr; 37(18):2511-2519. PubMed ID: 30940486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?
    Prada JM; Metcalf CJE; Takahashi S; Lessler J; Tatem AJ; Ferrari M
    Vaccine; 2017 Mar; 35(11):1488-1493. PubMed ID: 28216186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ; Orenstein WA
    Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles outbreaks and Supplemental Immunization Activities (SIAs): the Gwagwalada experience, Abuja 2015.
    Olugbade OT; Adeyemi AS; Adeoti AH; Ilesanmi OS; Gidado SO; Waziri NE; Aworh MK
    Pan Afr Med J; 2019; 32(Suppl 1):10. PubMed ID: 30949285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy.
    Verguet S; Johri M; Morris SK; Gauvreau CL; Jha P; Jit M
    Vaccine; 2015 Mar; 33(10):1291-6. PubMed ID: 25541214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress Toward Measles Elimination - Pakistan, 2000-2018.
    Mere MO; Goodson JL; Chandio AK; Rana MS; Hasan Q; Teleb N; Alexander JP
    MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(22):505-510. PubMed ID: 31170125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintaining high rates of measles immunization in Africa.
    Lessler J; Moss WJ; Lowther SA; Cummings DA
    Epidemiol Infect; 2011 Jul; 139(7):1039-49. PubMed ID: 20920382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of disruptions to routine vaccination programs, quantifying burden of measles, and mapping targeted supplementary immunization activities.
    Kostandova N; Loisate S; Winter A; Moss WJ; Giles JR; Metcalf CJE; Mutembo S; Wesolowski A
    Epidemics; 2022 Dec; 41():100647. PubMed ID: 36343498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002.
    Vijayaraghavan M; Martin RM; Sangrujee N; Kimani GN; Oyombe S; Kalu A; Runyago A; Wanjau G; Cairns L; Muchiri SN
    Health Policy; 2007 Sep; 83(1):27-36. PubMed ID: 17174435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles control in Sub-Saharan Africa: South Africa as a case study.
    Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
    Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scheduling of measles vaccination in low-income countries: projections of a dynamic model.
    Bauch CT; Szusz E; Garrison LP
    Vaccine; 2009 Jun; 27(31):4090-8. PubMed ID: 19410622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of WhatsApp group messaging in the coordination of measles supplemental immunization activity in Cross Rivers State, Nigeria, 2018.
    Masresha B; Nwankwo O; Bawa S; Igbu T; Oteri J; Tafida H; Braka F
    Pan Afr Med J; 2020; 35(Suppl 1):6. PubMed ID: 32373257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination strategies for measles control and elimination: time to strengthen local initiatives.
    Cutts FT; Ferrari MJ; Krause LK; Tatem AJ; Mosser JF
    BMC Med; 2021 Jan; 19(1):2. PubMed ID: 33397366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
    Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
    Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.